 |
|
apolizumab
A humanized monoclonal antibody directed against 1D10, a polymorphic determinant on the HLA-DR beta chain that is expressed on normal and neoplastic B cells. Apolizumab induces complement-mediated cytotoxicity, antibody-dependent cell-mediated cytotoxicity, and apoptosis of 1D10 antigen-positive B cells in vitro. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | 1D1O Anti-lymphoma Antibody
Monoclonal antibody 1D10
Monoclonal Antibody Hu1D10 | | | | US brand name: | | Remitogen | | | | Abbreviations: | | MOAB 1D10
MoAb Hu1D10 | | |
| Previous: | apatinib, apaziquone, APC8015F, apixaban, Aplidin | | Next: | apomab, apoptosis inducer BZL101, apoptosis inducer GCS-100, apoptosis inducer GMX1777, apoptosis inducer MPC-2130 |
|
|
